10/8/2022
The U.S. this week bought $290 million of a drug designed to treat blood cell injuries following radiological & nuclear emergencies as part of what it said were long-standing efforts to prepare for potential health impacts from threats to national security, per Reuters.
The U.S. Department of Health and Human Services purchased the drug Nplate from Amgen Inc.
When asked whether the purchase, announced Tuesday, was linked to tensions with Russia following its invasion of Ukraine, an HHS spokesperson said it was part of ongoing efforts to prepare for a wide range of threats including chemical, biological, radiological, nuclear, and emerging infectious diseases.
The White House has said repeatedly that it has seen no indication that Russia is preparing to use nuclear weapons despite what it calls Putin’s “nuclear saber-rattling.”
President Joe Biden said on Thursday the threat by Putin to use nuclear weapons in Ukraine has brought the world closer to “Armageddon” than at any time since the Cold-War Cuban Missile Crisis.
Full Link (ABC13) Here
Make sure you us on Facebook
